Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
ATLANTA, March 22, 2023 – With health equity issues in cancer care continuing to disproportionately impact medically under-resourced communities, the American Cancer Society (ACS) and Genentech,...
Dr. Arif Kamal, chief patient officer at the American Cancer Society, assumed the role of editor-in-chief of CA in late 2022. Dr. Don Dizon, a researcher and professor of medicine and surgery at Brown University, joins the journal as the new editor.
To help ensure equitable access to quality care, the American Cancer Society (ACS) and Dr. Stephen Klasko and his wife, Colleen Wyse, lifelong advocates for transformation in healthcare, will partner to launch a new research grant program, the Advancing Health Equity and Addressing Cancer Disparities (AHEAD) Awards.
In her new role, Mucci will address the alarming negative trends in prostate cancer incidence and disparities by focusing on growing and implementing a new ACS initiative called IMPACT, or “Improving Mortality Toward Prostate Cancer Together”.
On behalf of the nearly 300,000 women who will be diagnosed with breast cancer this year, the American Cancer Society (ACS) and American Cancer Society Cancer Action Network (ACS CAN) commend the Food and Drug Administration (FDA) for taking steps to modernize the Mammography Quality Standards Act (MQSA) which will help reduce breast cancer mortality.
The 80% in Every Community National Achievement Awards is a program designed to recognize individuals and organizations who are dedicating their time, talent and expertise to advancing needed initiatives that support the shared goal to reach colorectal screening rates of 80% and higher in communities across the nation.
The study found Black women in Delaware, Missouri, Louisiana, and Mississippi have the highest TNBC incidence rate, more than four times as much, compared to Asian or Pacific Islander women with the lowest rate.
Researchers showed the proportion of individuals in the United States diagnosed with advanced-stage colorectal cancer (CRC) increased from 52% in the mid-2000s to 60% in 2019. In addition, diagnoses of people under 55 years of age doubled from 11% (1 in 10) in 1995 to 20% (1 in 5) in 2019.
La Sociedad Americana Contra El Cáncer publica las nuevas estadísticas sobre el cáncer colorrectal; los cambios rápidos hacia enfermedades más avanzadas y las personas más jóvenes
According to a new, large study led by researchers at the American Cancer Society (ACS), millions of people in the United States continued to miss critical cancer screening tests during the second year of the COVID-19 pandemic.